✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Zota Health Care Ltd.

ZOTA

Market Cap
₹2,600 Cr.
P/E
0.00

Zota Health Care Ltd.

About
Zota Health Care is a pharmaceutical company that develops, manufactures, and markets generic, patented, and OTC pharmaceutical products in India and internationally. Their products include pharmaceut… Read more
Zota Health Care is a pharmaceutical company that develops, manufactures, and markets generic,… Read more
Low
440
52W Range
High
1078
  • Zota Health Care
  • Indoco Remedies
  • Novartis

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of Stores - Franchises (.)
      Source
    • Number of Stores (.)
      Source
    • Number of Stores - Company Owned (.)
      Source
    • Average Revenue Per User (ARPU) (Rs)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Zota Health Care Ltd. Business

    Zota Health Care is a pharmaceutical company that develops, manufactures, and markets generic, patented, and OTC pharmaceutical products in India and internationally through its distributor network.

    Zota Health Care major competitors are Indoco Remedies, Novartis, Panacea Biotec, Guj. Themis Biosyn, Beta Drugs, Gufic Biosciences, Syncom Formulations.
    Market Cap of Zota Health Care is ₹2,544 Crs.
    While the median market cap of its peers are ₹2,223 Crs.

    Zota Health Care seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Dec
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material